SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-016008
Filing Date
2024-06-07
Accepted
2024-06-07 16:41:20
Documents
1
Period of Report
2024-03-27

Document Format Files

Seq Description Document Type Size
1 form4-06072024_080616.html 4  
1 form4-06072024_080616.xml 4 6569
  Complete submission text file 0001415889-24-016008.txt   8072
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVE BEDFORD MA 01730
Business Address
Nash Huw M. (Reporting) CIK: 0001780085 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 241030246